Skip to main content
YIFAN PHARMACEUTICAL CO.,LTD logo

YIFAN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002019 ISIN · CNE000001K65 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2026-05-21 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 002019

About YIFAN PHARMACEUTICAL CO.,LTD

https://www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and commercialization of innovative biologics, specialty small molecules, and traditional Chinese medicine. The company maintains a diverse product portfolio, notably featuring Ryzneuta (efbemalenograstim alfa), a long-acting recombinant human granulocyte colony-stimulating factor used to treat chemotherapy-induced neutropenia. It is also recognized as a major global supplier of Vitamin B5 (D-calcium pantothenate). Operating with a global perspective, the firm manages integrated R&D and production platforms that adhere to international quality standards. Its core activities span drug discovery, clinical development, and large-scale manufacturing, with a strategic emphasis on therapeutic areas such as oncology, hematology, and dermatology.

Recent filings

Filing Released Lang Actions
2025年年度分红派息实施公告
Notice of Dividend Amount Classification · 91% confidence The document is an official announcement detailing the company’s 2025 annual dividend distribution plan, specifying the dividend amount per share, record date, ex-dividend date, payment method, and related procedures. This matches the definition of a Notice of Dividend Amount (DIV).
2026-05-21 Chinese
安徽天禾律师事务所关于亿帆医药股份有限公司2025年年度股东会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 80% confidence The document is a legal opinion letter from a law firm covering the company’s 2025 Annual General Meeting, with exhaustive tables of vote counts and approval percentages for each resolution. It provides the formal, official voting results of the AGM (e.g. votes for the 2025 board report, annual report, profit distribution proposal, auditor reappointment, remuneration resolution, etc.). This matches the “Declaration of Voting Results & Voting Rights Announcements” category, which covers official vote results from shareholder meetings.
2026-05-18 Chinese
关于全资子公司收到药品注册受理通知书的公告
Regulatory Filings Classification · 82% confidence The document is a formal public announcement by a listed company regarding its subsidiary receiving a drug registration acceptance notice from the national drug regulator. It does not contain financial statements, executive certifications, or meeting materials, nor is it an earnings release, share transaction, or governance filing. This fits the general regulatory announcement category (fallback).
2026-05-15 Chinese
关于全资子公司再次通过高新技术企业认定的公告
Regulatory Filings Classification · 85% confidence The document is a company announcement regarding its subsidiaries receiving new high-tech enterprise certificates, detailing the certificate numbers, issue dates, validity periods, and the impact on tax benefits and operations. It is a routine regulatory/compliance disclosure and does not contain financial statements, management discussion, or other specialized content. Therefore, it falls under general regulatory filings.
2026-05-15 Chinese
关于全资子公司获得药物临床试验批准通知书的公告
Regulatory Filings Classification · 92% confidence The document is a regulatory announcement by a listed company on the receipt of a clinical trial approval notification from the National Medical Products Administration. It does not contain financial statements, management change information, capital raising details, or other specific report types. It is a general regulatory/compliance announcement, which falls under the fallback category Regulatory Filings (RNS).
2026-05-13 Chinese
关于第九届董事会董事、高级管理人员薪酬方案的公告
Regulatory Filings
2026-04-23 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.